Identification and in silico characterization of a novel compound heterozygosity associated with hereditary aceruloplasminemia

References

• Miyajima H. Aceruloplasminemia, an iron metabolic disorder. Neuropathology 2003; 23: 345–50
   PubMed Web of Science ®Google Scholar
• Nittis T, Gitlin JD. The copper-iron connection: hereditary aceruloplasminemia. Semin Hematol 2002; 39: 282–9
   PubMedGoogle Scholar
• Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 1987; 37: 761–7
   PubMed Web of Science ®Google Scholar
• Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RT, Gitlin JD. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 1995; 92: 2539–43
   PubMed Web of Science ®Google Scholar
• Zaitsev VN, Zaitseva I, Papiz M, Lindley PF. An x-ray crystallographic study of the binding sites of the azide inhibitor and organic substrates to ceruloplasmin, a multi-copper oxidase in the plasma. J Biol Inorg Chem 1999; 4: 579–87
   PubMed Web of Science ®Google Scholar
• Bielli P, Calabrese L. Structure to function relationships in ceruloplasmin: a “moonlighting” protein. Cell Mol Life Sci 2002; 59: 1413–27
   PubMed Web of Science ®Google Scholar
• Bertini P, Sigel A, Sigel H. Handbook on metalloprotein. Marcel Dekker, New York 2001; 763–811
   Google Scholar
• Bairoch A, Apweiler R, Wu CH, Barker WC, Boeckmann B, Ferro S, et al. The Universal Protein Resource (UniProt). Nucleic Acids Res 2005; 33: D154–9
   PubMed Web of Science ®Google Scholar
• Altschul SF, Koonin EV. Iterated profile searches with PSI-BLAST: a tool for discovery in protein databases. Trends Biochem Sci 1998; 23: 444–7
   PubMed Web of Science ®Google Scholar
• Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, Higgins DG, et al. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res 2003; 31: 3497–500
   PubMed Web of Science ®Google Scholar
• Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 1983; 22: 2577–637
   PubMed Web of Science ®Google Scholar
• Westbrook J, Feng Z, Chen L, Yang H, Berman HM. The protein data bank and structural genomics. Nucleic Acids Res 2003; 31: 489–91
   PubMed Web of Science ®Google Scholar
• Landau M, Mayrose I, Rosenberg Y, Glaser F, Martz E, Pupko T, et al. ConSurf : the projection of evolutionary conservation scores of residues on protein structures. Nucleic Acids Res 2005; 33: W299–302
   PubMed Web of Science ®Google Scholar
• Graham JM, Paley MN, Grunewald RA, Hoggard N, Griffiths PD. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 2000; 123: 2423–31
   PubMedGoogle Scholar
• Miyajima H, Takahashi Y, Kamata T, Shimizu H, Sakai N, Gitlin JD. Use of desferrioxamine in the treatment of aceruloplasminemia. Ann Neurol 1997; 41: 404–7
   PubMed Web of Science ®Google Scholar
• Mariani R, Arosio C, Pelucchi S, Grisoli M, Piga A, Trombini P, et al. Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation. Gut 2004; 53: 756–8
   PubMed Web of Science ®Google Scholar
• Daimon M, Kato T, Kawanami T, Tominaga M, Igarashi M, Yamatani K, et al. A nonsense mutation of the ceruloplasmin gene in hereditary ceruloplasmin deficiency with diabetes mellitus. Biochem Biophys Res Commun 1995; 217: 89–95
   PubMedGoogle Scholar
• Yoshida K, Furihata K, Takeda S, Nakamura A, Yamamoto K, Morita H, et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet 1995; 9: 267–72
   PubMed Web of Science ®Google Scholar
• Okamoto N, Wada S, Oga T, Kawabata Y, Baba Y, Habu D, et al. Hereditary ceruloplasmin deficiency with hemosiderosis. Hum Genet 1996; 97: 755–8
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Miyajima H, Shirabe S, Nagataki S, Suenaga A, Gitlin JD. Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease. Hum Mol Genet 1996; 5: 81–4
   PubMedGoogle Scholar
• Yazaki M, Yoshida K, Nakamura A, Furihata K, Yonekawa M, Okabe T, et al. A novel splicing mutation in the ceruloplasmin gene responsible for hereditary ceruloplasmin deficiency with hemosiderosis. J Neurol Sci 1998; 156: 30–4
   PubMedGoogle Scholar
• Miyajima H, Kohno S, Takahashi Y, Yonekawa O, Kanno T. Estimation of the gene frequency of aceruloplasminemia in Japan. Neurology 1999; 53: 617–9
   PubMed Web of Science ®Google Scholar
• Hellman NE, Schaefer M, Gehrke S, Stegen P, Hoffman WJ, Gitlin JD, et al. Hepatic iron overload in aceruloplasminaemia. Gut 2000; 47: 858–60
   PubMed Web of Science ®Google Scholar
• Kohno S, Miyajima H, Takahashi Y, Inoue Y. Aceruloplasminemia with a novel mutation associated with parkinsonism. Neurogenetics 2000; 2: 237–8
   PubMedGoogle Scholar
• Bosio S, De Gobbi M, Roetto A, Zecchina G, Leonardo E, Rizzetto M, et al. Anemia and iron overload due to compound heterozygosity for novel ceruloplasmin mutations. Blood 2002; 100: 2246–8
   PubMed Web of Science ®Google Scholar
• Hellman NE, Kono S, Miyajima H, Gitlin JD. Biochemical analysis of a missense mutation in aceruloplasminemia. J Biol Chem 2002; 277: 1375–80
   PubMedGoogle Scholar
• Loreal O, Turlin B, Pigeon C, Moisan A, Ropert M, Morice P, et al. Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights. J Hepatol 2002; 36: 851–6
   PubMed Web of Science ®Google Scholar
• Hatanaka Y, Okano T, Oda K, Yamamoto K, Yoshida K. Aceruloplasminemia with juvenile-onset diabetes mellitus caused by exon skipping in the ceruloplasmin gene. Intern Med 2003; 42: 599–604
   PubMedGoogle Scholar
• Kuhn J, Miyajima H, Takahashi Y, Kunath B, Hartmann-Klosterkoetter U, Cooper-Mahkorn D, et al. Extrapyramidal and cerebellar movement disorder in association with heterozygous ceruloplasmin gene mutation. J Neurol 2005; 252: 111–3
   PubMed Web of Science ®Google Scholar
• Perez-Aguilar F, Burguera JA, Benlloch S, Berenguer M, Rayon JM. Aceruloplasminemia in an asymptomatic patient with a new mutation. Diagnosis and family genetic analysis. J Hepatol 2005; 42: 947–9
   PubMed Web of Science ®Google Scholar
• Hellman NE, Kono S, Mancini GM, Hoogeboom AJ, De Jong GJ, Gitlin JD. Mechanisms of copper incorporation into human ceruloplasmin. J Biol Chem 2002; 277: 46632–8
   PubMed Web of Science ®Google Scholar
• Gitlin JD, Schroeder JJ, Lee-Ambrose LM, Cousins RJ. Mechanisms of caeruloplasmin biosynthesis in normal and copper-deficient rats. Biochem J 1992; 282: 835–9
   PubMed Web of Science ®Google Scholar
• Holtzman NA, Gaumnitz BM. Studies on the rate of release and turnover of ceruloplasmin and apoceruloplasmin in rat plasma. J Biol Chem 1970; 245: 2354–8
   PubMed Web of Science ®Google Scholar
• Koschinsky ML, Funk WD, van Oost BA, MacGillivray RT. Complete cDNA sequence of human preceruloplasmin. Proc Natl Acad Sci USA 1986; 83: 5086–90
   PubMed Web of Science ®Google Scholar
• Klomp LW, Farhangrazi ZS, Dugan LL, Gitlin JD. Ceruloplasmin gene expression in the murine central nervous system. J Clin Invest 1996; 98: 207–15
   PubMed Web of Science ®Google Scholar
• Fleming RE, Gitlin JD. Primary structure of rat ceruloplasmin and analysis of tissue-specific gene expression during development. J Biol Chem 1990; 265: 7701–7
   PubMed Web of Science ®Google Scholar
• Syed BA, Beaumont NJ, Patel A, Naylor CE, Bayele HK, Joannou CL, et al. Analysis of the human hephaestin gene and protein: comparative modelling of the N-terminus ecto-domain based upon ceruloplasmin. Protein Eng 2002; 15: 205–14
   PubMedGoogle Scholar
• Vulpe CD, Kuo YM, Murphy TL, Cowley L, Askwith C, Libina N, et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the SLA mouse. Nat Genet 1999; 21: 195–9
   PubMed Web of Science ®Google Scholar
• Frazer DM, Vulpe CD, McKie AT, Wilkins SJ, Trinder D, Cleghorn GJ, et al. Cloning and gastrointestinal expression of rat hephaestin: relationship to other iron transport proteins. Am J Physiol Gastrointest Liver Physiol 2001; 281: G931–9
   PubMed Web of Science ®Google Scholar
• Truett MA, Blacher R, Burke RL, Caput D, Chu C, Dina D, et al. Characterization of the polypeptide composition of human factor VIII:C and the nucleotide sequence and expression of the human kidney cDNA. DNA 1985; 4: 333–49
   PubMedGoogle Scholar
• Cameron C, Notley C, Hoyle S, McGlynn L, Hough C, Kamisue S, et al. The canine factor VIII cDNA and 5′ flanking sequence. Thromb Haemost 1998; 79: 317–22
   PubMedGoogle Scholar
• Toole JJ, Pittman DD, Orr EC, Murtha P, Wasley LC, Kaufman RJ. A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity. Proc Natl Acad Sci USA 1986; 83: 5939–42
   PubMed Web of Science ®Google Scholar
• Elder B, Lakich D, Gitschier J. Sequence of the murine factor VIII cDNA. Genomics 1993; 16: 374–9
   PubMedGoogle Scholar
• Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, et al. Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 1987; 84: 4846–50
   PubMed Web of Science ®Google Scholar
• Grimm DR, Colter MB, Braunschweig M, Alexander LJ, Neame PJ, Kim HK. Porcine factor V: cDNA cloning, gene mapping, three-dimensional protein modeling of membrane binding sites and comparative anatomy of domains. Cell Mol Life Sci 2001; 58: 148–59
   PubMedGoogle Scholar
• Guinto ER, Esmon CT, Mann KG, MacGillivray RT. The complete cDNA sequence of bovine coagulation factor V. J Biol Chem 1992; 267: 2971–8
   PubMedGoogle Scholar